Double Tympanocentesis Studies: Bridging from Bacteriological Outcome to Studies with Clinical Outcome

7/19/02

Click here to start

Table of Contents

Double Tympanocentesis Studies: Bridging from Bacteriological Outcome to Studies with Clinical Outcome

NTHi Eradication Rate: Amox/Clav (45mg/kg) vs. Azithromycin

Clinical Success: Amox/Clav (45mg/kg) vs. Azithromycin

Clinical Success: Amox/Clav (45mg/kg) vs. Azithromycin

Study 1015 (Single Dose Azithro 30 mg/kg) Conducted by Pfizer by Penicillin Susceptibility

Clinical Success in Studies Conducted by Pfizer by by Pathogens

Clinical Recurrence After Completion of Rx vs Bacteriologic Relapse

New Acquisition vs Persistence of Pathogens in Clinical Recurrence of AOM in Relation to Initial AOM Isolate*

Author: prof. Ron Dagan